icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
mHZskpFN4aEBPyAz
Listen
